Cumberland Pharmaceuticals (CPIX) insider buying
20 open-market purchases of CPIX by Cumberland Pharmaceuticals's executives and directors since November 2022, worth $1,086 in total, from SEC Form 4 filings.
The most recent: James Jones bought $195 on December 21, 2022.
The biggest buyer over the period is Caroline Young: 19 purchases, $891.
By year
| Year | Purchases | Value |
|---|---|---|
| 2022 | 20 | $1,086 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Caroline Young | 19 | $891 |
| James Jones | 1 | $195 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 21, 2022 | James Jones |
88 | $2.22 | $195 | Form 4 |
| Dec 19, 2022 | Caroline Young |
30 | $2.21 | $66 | Form 4 |
| Dec 16, 2022 | Caroline Young |
20 | $2.22 | $44 | Form 4 |
| Dec 14, 2022 | Caroline Young |
20 | $2.21 | $44 | Form 4 |
| Dec 12, 2022 | Caroline Young |
20 | $2.14 | $43 | Form 4 |
| Dec 9, 2022 | Caroline Young |
20 | $2.15 | $43 | Form 4 |
| Dec 7, 2022 | Caroline Young |
20 | $2.18 | $44 | Form 4 |
| Dec 5, 2022 | Caroline Young |
20 | $2.19 | $44 | Form 4 |
| Dec 1, 2022 | Caroline Young |
20 | $2.33 | $47 | Form 4 |
| Nov 28, 2022 | Caroline Young |
20 | $2.37 | $47 | Form 4 |
| Nov 25, 2022 | Caroline Young |
20 | $2.31 | $46 | Form 4 |
| Nov 23, 2022 | Caroline Young |
20 | $2.29 | $46 | Form 4 |
| Nov 21, 2022 | Caroline Young |
20 | $2.38 | $48 | Form 4 |
| Nov 18, 2022 | Caroline Young |
20 | $2.27 | $45 | Form 4 |
| Nov 16, 2022 | Caroline Young |
20 | $2.31 | $46 | Form 4 |
| Nov 14, 2022 | Caroline Young |
20 | $2.32 | $46 | Form 4 |
| Nov 11, 2022 | Caroline Young |
20 | $2.32 | $46 | Form 4 |
| Nov 9, 2022 | Caroline Young |
20 | $2.37 | $47 | Form 4 |
| Nov 7, 2022 | Caroline Young |
20 | $2.45 | $49 | Form 4 |
| Nov 4, 2022 | Caroline Young |
20 | $2.42 | $48 | Form 4 |
Questions
Are Cumberland Pharmaceuticals insiders buying the stock?
20 open-market purchases of CPIX by Cumberland Pharmaceuticals's executives and directors since November 2022, worth $1,086 in total, from SEC Form 4 filings. The most recent: James Jones bought $195 on December 21, 2022.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Cumberland Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.